CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
Orixha's project focuses on improving critical care for cardiac arrest patients using its innovative LuncoLive technology. This involves the Vent2Cool device, which provides rapid cooling to protect the heart and brain, aiming to enhance survival rates and establish new standards in post-resuscitation care.
Orixha offers a major clinical breakthrough in Critical Care with its unique LUNg COnservative LIquid VEntilation (hence LuncoLive) technology.
It powers the Vent2Cool medical device to induce ultra-rapid protective cooling of heart and brain of resuscitated cardiac arrest patients.
Vent2Cool will increase their survival rate by tackling the reperfusion injury of Post Cardiac Arrest Syndrome .LuncoLive project will enable clinical validation of Vent2Cool as a new gold standard for post-resuscit…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
